NYSE:RAD

Rite Aid Stock Forecast, Price & News

$20.14
-1.11 (-5.22 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$20.07
$21.15
50-Day Range
$16.80
$22.53
52-Week Range
$8.85
$32.48
Volume1.76 million shs
Average Volume2.35 million shs
Market Capitalization$1.11 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.83
30 days | 90 days | 365 days | Advanced Chart
Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.


Rite Aid logo

About Rite Aid

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, pet care, and other every day and convenience products, as well as brand and generic prescription drugs. It also operates retail clinics that provide treatment for common conditions; and provides preventative services. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of April 28, 2021, the company operated approximately 2,500 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

0.83 out of 5 stars

Retail/Wholesale Sector

247th out of 402 stocks

Drug Stores & Proprietary Stores Industry

8th out of 14 stocks

Analyst Opinion: 0.8Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Rite Aid (NYSE:RAD) Frequently Asked Questions

Is Rite Aid a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Rite Aid stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RAD, but not buy additional shares or sell existing shares.
View analyst ratings for Rite Aid
or view top-rated stocks.

What stocks does MarketBeat like better than Rite Aid?

Wall Street analysts have given Rite Aid a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Rite Aid wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release its next quarterly earnings announcement on Thursday, June 24th 2021.
View our earnings forecast for Rite Aid
.

How can I listen to Rite Aid's earnings call?

Rite Aid will be holding an earnings conference call on Thursday, June 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) released its quarterly earnings results on Wednesday, April, 14th. The company reported ($0.78) earnings per share for the quarter, topping analysts' consensus estimates of ($0.79) by $0.01. The firm had revenue of $5.92 billion for the quarter, compared to analysts' expectations of $5.81 billion. Rite Aid had a negative trailing twelve-month return on equity of 1.42% and a negative net margin of 0.38%. Rite Aid's revenue was up 3.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.37) earnings per share.
View Rite Aid's earnings history
.

How has Rite Aid's stock price been impacted by COVID-19?

Rite Aid's stock was trading at $14.13 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RAD shares have increased by 42.5% and is now trading at $20.14.
View which stocks have been most impacted by COVID-19
.

When did Rite Aid's stock split? How did Rite Aid's stock split work?

Rite Aid shares reverse split on the morning of Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid issued an update on its first quarter 2022 earnings guidance on Tuesday, May, 4th. The company provided earnings per share guidance of - for the period. The company issued revenue guidance of $6.10 billion-$6.30 billion, compared to the consensus revenue estimate of $6.05 billion.

What price target have analysts set for RAD?

3 brokers have issued twelve-month price objectives for Rite Aid's stock. Their forecasts range from $6.00 to $27.00. On average, they expect Rite Aid's stock price to reach $16.67 in the next twelve months. This suggests that the stock has a possible downside of 17.2%.
View analysts' price targets for Rite Aid
or view top-rated stocks among Wall Street analysts.

Who are Rite Aid's key executives?

Rite Aid's management team includes the following people:
  • Ms. Heyward Rutledge Donigan B.A., Pres CEO & Director (Age 60, Pay $4.62M)
  • Mr. Matthew C. Schroeder, CFO & Exec. VP (Age 51, Pay $1.13M)
  • Mr. James Joseph Peters Jr., Chief Operating Officer (Age 49, Pay $558.62k)
  • Ms. Jocelyn Zazyczny Konrad, Exec. VP & Chief Pharmacy Officer (Age 51, Pay $1.25M)
  • Mr. Brian T. Hoover, Chief Accounting Officer & Sr. VP (Age 56)
  • Mr. Justin L. Mennen, Exec. VP & Chief Information Officer (Age 40)
  • Byron Purcell, Sr. Director of Treasury Services & Investor Relations
  • Mr. Trent Kruse, Sr. VP of Investor Relations & Treasury
  • Mr. Paul D. Gilbert, Exec. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Ms. Susan K. Henderson, Chief Communications Officer & Sr. VP (Age 68)

What is Heyward Donigan's approval rating as Rite Aid's CEO?

169 employees have rated Rite Aid CEO Heyward Donigan on Glassdoor.com. Heyward Donigan has an approval rating of 58% among Rite Aid's employees. This puts Heyward Donigan in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Rite Aid's key competitors?

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), (CELG), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and CVS Health (CVS).

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.08%), Renaissance Technologies LLC (3.08%), Great Lakes Advisors LLC (1.87%), Geode Capital Management LLC (1.69%), Dimensional Fund Advisors LP (1.64%) and Northern Trust Corp (1.38%).
View institutional ownership trends for Rite Aid
.

Which major investors are selling Rite Aid stock?

RAD stock was sold by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Alberta Investment Management Corp, Eversept Partners LP, Millennium Management LLC, Northern Trust Corp, Morgan Stanley, Cubist Systematic Strategies LLC, and BNP Paribas Arbitrage SA.
View insider buying and selling activity for Rite Aid
or view top insider-selling stocks.

Which major investors are buying Rite Aid stock?

RAD stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, BlackRock Inc., Dimensional Fund Advisors LP, Point72 Asset Management L.P., Goldman Sachs Group Inc., Citigroup Inc., UBS Group AG, and JPMorgan Chase & Co..
View insider buying and selling activity for Rite Aid
or or view top insider-buying stocks.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $20.14.

How much money does Rite Aid make?

Rite Aid has a market capitalization of $1.11 billion and generates $24.04 billion in revenue each year. The company earns $-90,910,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis.

How many employees does Rite Aid have?

Rite Aid employs 50,000 workers across the globe.

Does Rite Aid have any subsidiaries?

The following companies are subsidiares of Rite Aid: 1515 West State Street Boise Idaho LLC, 1740 Associates LLC, 4042 Warrensville Center Road—Warrensville Ohio Inc., 5277 Associates Inc., 5600 Superior Properties Inc., Advance Benefits LLC, Apex Drug Stores Inc., Ascend Health Technology LLC, Bartell Drugs, Broadview and Wallings—Broadview Heights Ohio Inc., Design Rx Holdings LLC, Design Rx LLC, Design Rxclusives LLC, Drug Palace Inc., EDC Drug Stores Inc., Eckerd Corporation, Edgehill Drugs, Elixir Insurance Company, Elixir Pharmacy LLC, Elixir Rx Options LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions of Nevada LLC, Elixir Savings LLC, Envision Pharmaceutical, Envision Pharmaceutical Holdings LLC, EnvisionRx Puerto Rico Inc., First Florida Insurers of Tampa LLC, GDF Inc., Genovese Drug Stores Inc., Gettysburg and Hoover-Dayton Ohio LLC, Grand River & Fenkell LLC, Harco, Harco Inc., Health Dialog, Health Dialog Services Corporation, Hunter Lane LLC, ILG – 90 B Avenue Lake Oswego LLC, JCG (PJC) USA LLC, JCG Holdings (USA) Inc., K&B Alabama Corporation, K&B Incorporated, K&B Industries, K&B Louisiana Corporation, K&B Mississippi Corporation, K&B Services Incorporated, K&B Tennessee Corporation, K&B Texas Corporation, LMW – 90B Avenue Lake Oswego Inc., Lakehurst and Broadway Corporation, Laker Software LLC, Maxi Drug Inc., Maxi Drug North Inc., Maxi Drug South L.P., Maxi Green Inc., Munson & Andrews LLC, Name Rite LLC, P.J.C. Distribution Inc., P.J.C. Realty Co. Inc., PCS Health Systems, PDS-1 Michigan Inc., PJC Lease Holdings Inc., PJC Manchester Realty LLC, PJC Peterborough Realty LLC, PJC Realty MA Inc., PJC Revere Realty LLC, PJC Special Realty Holdings Inc., PJC of Massachusetts Inc., PJC of Rhode Island Inc., PJC of Vermont Inc., Perry Distributors Inc., Perry Drug Stores Inc., RCMH LLC, RDS Detroit Inc., READ’s Inc., RediClinic, RediClinic Associates Inc., RediClinic LLC, RediClinic US LLC, RediClinic of DC LLC, RediClinic of DE LLC, RediClinic of Dallas Forth-Worth LLC, RediClinic of MD LLC, RediClinic of PA LLC, RediClinic of VA LLC, Richfield Road – Flint Michigan LLC, Rite Aid Drug Palace Inc., Rite Aid Hdqtrs. Corp., Rite Aid Hdqtrs. Funding Inc., Rite Aid Lease Management Company, Rite Aid Online Store Inc., Rite Aid Payroll Management Inc., Rite Aid Realty Corp., Rite Aid Rome Distribution Center Inc., Rite Aid Specialty Pharmacy LLC, Rite Aid Transport Inc., Rite Aid of Connecticut Inc., Rite Aid of Delaware Inc., Rite Aid of Georgia Inc., Rite Aid of Indiana Inc., Rite Aid of Kentucky Inc., Rite Aid of Maine Inc., Rite Aid of Maryland Inc., Rite Aid of Michigan Inc., Rite Aid of New Hampshire Inc., Rite Aid of New Jersey Inc., Rite Aid of New York Inc., Rite Aid of North Carolina Inc., Rite Aid of Ohio Inc., Rite Aid of Pennsylvania LLC, Rite Aid of South Carolina Inc., Rite Aid of Tennessee Inc., Rite Aid of Vermont Inc., Rite Aid of Virginia Inc., Rite Aid of Washington D.C. Inc., Rite Aid of West Virginia Inc., Rite Investments Corp., Rite Investments Corp. LLC, Rx Choice Inc., Rx Initiatives LLC, Rx USA Inc., The Bartell Drug Company, The Jean Coutu Group (PJC) USA Inc., The Lane Drug Company, Thrift Drug Inc., Thrifty Corporation, and Thrifty PayLess Inc..

When was Rite Aid founded?

Rite Aid was founded in 1968.

What is Rite Aid's official website?

The official website for Rite Aid is www.riteaid.com.

Where are Rite Aid's headquarters?

Rite Aid is headquartered at 30 Hunter Lane, Camp Hill PA, 17105.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]


This page was last updated on 6/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.